Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) EBIT Margin (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed EBIT Margin for 16 consecutive years, with 51.65% as the latest value for Q4 2025.

  • On a quarterly basis, EBIT Margin fell 7472.0% to 51.65% in Q4 2025 year-over-year; TTM through Dec 2025 was 6.33%, a 1744.0% decrease, with the full-year FY2025 number at 6.33%, down 1744.0% from a year prior.
  • EBIT Margin was 51.65% for Q4 2025 at Lemaitre Vascular, down from 33.27% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 33.27% in Q3 2025 to a low of 51.65% in Q4 2025.
  • A 5-year average of 17.97% and a median of 21.05% in 2025 define the central range for EBIT Margin.
  • Biggest YoY gain for EBIT Margin was 929bps in 2025; the steepest drop was -7472bps in 2025.
  • Lemaitre Vascular's EBIT Margin stood at 21.01% in 2021, then decreased by -19bps to 17.01% in 2022, then grew by 23bps to 20.88% in 2023, then rose by 10bps to 23.07% in 2024, then crashed by -324bps to 51.65% in 2025.
  • Per Business Quant, the three most recent readings for LMAT's EBIT Margin are 51.65% (Q4 2025), 33.27% (Q3 2025), and 25.13% (Q2 2025).